Clinical Trial Update: Atorvastatin Effect on Reduction of COPD Exacerbations [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating atorvastatin for reducing COPD exacerbations; study status is active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease
• Exacerbation of Chronic Obstructive Pulmonary Disease

Drugs mentioned

• atorvastatin (atorvastatin)

Snippet

Sponsor: Medical University of Bialystok | Conditions: Copd, COPD Exacerbation | Phase 4 | Status: ACTIVE_NOT_RECRUITING